These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11274040)

  • 1. ARMS allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast.
    Hodgson DR; Clayton SJ; Girdler F; Brotherick I; Shenton B; Browell D; Stuart M; Fox JC; Ceuppens P; Foy CA; Whitcombe D; Gibson NJ
    Clin Chem; 2001 Apr; 47(4):774-8. PubMed ID: 11274040
    [No Abstract]   [Full Text] [Related]  

  • 2. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Moll UM; Riou G; Levine AJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7262-6. PubMed ID: 1353891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating nucleic acids (CNAs) and cancer--a survey.
    Fleischhacker M; Schmidt B
    Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis for p53 overexpression in human breast cancer.
    Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
    Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
    Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
    Shao ZM; Wu J; Shen ZZ; Nguyen M
    Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
    Liang DH; Ensor JE; Liu ZB; Patel A; Patel TA; Chang JC; Rodriguez AA
    Breast Cancer Res Treat; 2016 Jan; 155(1):139-49. PubMed ID: 26667234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry.
    Mitsumoto Y; Nakajima T; Marutani M; Kashiwazaki H; Moriguchi M; Kimura H; Okanoue T; Kagawa K; Tada M
    Hum Pathol; 2004 Mar; 35(3):350-6. PubMed ID: 15017592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.
    Hoang MP; Callender DL; Sola Gallego JJ; Huang Z; Sneige N; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2001 Oct; 19(4):865-71. PubMed ID: 11562768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of p53 mutations in bilateral breast carcinoma.
    Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
    Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Mutation analysis in breast tumors by a DNA microarray method.
    Tennis M; Krishnan S; Bonner M; Ambrosone CB; Vena JE; Moysich K; Swede H; McCann S; Hall P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):80-5. PubMed ID: 16434591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the h-warts/LATS1 gene in human breast cancer.
    Morinaga N; Shitara Y; Yanagita Y; Koida T; Kimura M; Asao T; Kimijima I; Takenoshita S; Hirota T; Saya H; Kuwano H
    Int J Oncol; 2000 Dec; 17(6):1125-9. PubMed ID: 11078797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
    Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
    Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.
    Balogh GA; Mailo DA; Corte MM; Roncoroni P; Nardi H; Vincent E; Martinez D; Cafasso ME; Frizza A; Ponce G; Vincent E; Barutta E; Lizarraga P; Lizarraga G; Monti C; Paolillo E; Vincent R; Quatroquio R; Grimi C; Maturi H; Aimale M; Spinsanti C; Montero H; Santiago J; Shulman L; Rivadulla M; Machiavelli M; Salum G; Cuevas MA; Picolini J; Gentili A; Gentili R; Mordoh J
    Int J Oncol; 2006 Apr; 28(4):995-1002. PubMed ID: 16525651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
    Nakauchi C; Kagara N; Shimazu K; Shimomura A; Naoi Y; Shimoda M; Kim SJ; Noguchi S
    Clin Breast Cancer; 2016 Oct; 16(5):418-423. PubMed ID: 27265061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
    Ooe A; Kato K; Noguchi S
    Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.
    Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU
    Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.